Oncology & Cancer

Treatment nonexistent for some glioblastoma patients

Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.

Oncology & Cancer

FDA approves new skin cancer drug

A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable ...

Oncology & Cancer

Mutation in gene IDH a possible target for AML treatment

Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study published this week in the journal Leukemia & Lymphoma shows that this IDH mutation may be ...

Oncology & Cancer

Higher surgical volume may improve outcomes in cervical cancer

(HealthDay)—Surgery at high-volume centers is associated with decreased local recurrence risk and improved survival for women with early-stage cervical cancer, according to a study published in the June issue of Obstetrics ...

Oncology & Cancer

Study finds advances in breast cancer don't extend to older women

The survival rates for older women with breast cancer lag behind younger women diagnosed with the disease, indicating that the elder population may be missing out on improvements in treatment and detection, according to new ...

page 21 from 40